PDCD1 and neoplasm: In SubQ‐only mice, tumors responded to anti‐PD‐1 treatment as expected,[10, 11] evidenced by significantly reduced tumor growth and enhanced survival rates (Figure 1C,D, and Figure S1D, Supporting Information).